One of the country's largest providers of private Medicare plans saw its stock sink to its lowest level in 15 years after the federal government cut the rating for one of its most popular offerings.

Humana Inc.'s stock closed down another 1.9% on Thursday to bring its week-to-date losses to 24.3%, after BofA Securities downgraded it to underperform - or sell - on concerns about a delay in margin ...

Annual National Conference was held Sep. 4-6 in Orlando, Florida. Managed Healthcare Executive is the official publication of ...

Humana's (HUM) 2026 financial results are likely to see a "significant headwind" from potentially losing its 2025 Medicare Advantage quality star ratings, BofA Securities said in a note e-mailed ...

UnitedHealth asked a federal judge to block CMS from lowering the insurer’s 2025 Medicare Advantage quality ratings ...

Only 25% of Humana members will be in plans with four stars or above next year, down from 94% this year, the insurer ...

Humana's stock took a tumble after the provider admitted to the SEC that only about 1 in 4 of its members were signed up to Medicare Advantage plans rated four stars or more. Meanwhile, CMS is making ...

U.S. stock futures are pointing lower as turmoil in the Middle East is causing oil prices to rise; Levi Strauss shares are ...

Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Steve Baxter from ...

The stock slid more than 10% as the health insurer warned that a steep drop in the federal government’s quality ratings of ...

The insurer said the share of its customers currently enrolled in plans rated four stars or higher for 2025 is down to 25% ...